KINS is a microbiome-focused health tech company with the mission of “freeing the world from chronic diseases and symptoms through the power of bacteria.” Its strength lies in combining medical expertise with B2C marketing expertise. KINS integrates three businesses: a product business with more than 120,000 cumulative users (for women and men); a clinic business that serves as a place for treating and conducting clinical research on bacteria-related chronic diseases and symptoms (two veterinary hospitals in Japan and one clinic for people in Singapore); and a drug discovery business that aims to develop new treatments for chronic diseases and symptoms using data and samples obtained through both businesses. Through these, it aims to free more people and animals from bacteria-related chronic diseases and symptoms.
KINS PRIME, a new business focused on improving the performance of busy businesspeople, is currently growing rapidly.